Positions

Overview

  • Dr. Jeffrey R Curtis is a Professor of Medicine in the Division of Clinical Immunology and Rheumatology at the University of Alabama at Birmingham (UAB). Dr. Curtis received a Medical Degree (MD) and a Master of Public Health (MPH) degree from Oregon Health & Sciences University in Portland, OR. He subsequently completed a residency in internal medicine at Oregon Health & Science University and a fellowship in rheumatology at UAB. He completed a graduate program in Clinical Informatics at Stanford University and received his Master of Science (MS) degree in epidemiology at the Harvard School of Public Health. He is board certified in both rheumatology and clinical informatics. Dr. Curtis currently holds the Marguerite Jones Harbert – Gene V. Ball Endowed Professorship in Rheumatology and Immunology at UAB. He is the Co-Director of the UAB Pharmacoepidemiology and Pharmacoeconomics Research (PEER) Unit. PEER uses multiple large data sources to study comparative effectiveness questions across multiple chronic diseases. These data sources include national administrative data from Medicare and commercial health plans, electronic health record data, and large registries. In 2012, he was awarded the Henry Kunkel Young Investigator Award by the American College of Rheumatology (ACR) and was accepted into the American Society for Clinical Investigation (ASCI) in 2016. The evaluation of the efficacy, comparative effectiveness, and safety of the medications used to treat rheumatoid arthritis and spondyloarthritis are among Dr. Curtis’s research interests. He served on the Core Expert Panel for the ACR’s 2008, 2012, and 2015 Recommendations for the Use of Nonbiologic and Biologic Disease Modifying Antirheumatic Drugs in RA. He was the Deputy Director for a collaborative project between the FDA, the Agency for Healthcare Research and Quality (AHRQ), and a number of academic centers studying the safety of biologic agents using multiple, pooled national data sources. He is the Co-PI of the PCORI-funded Patient Powered Research Network “Arthritis-Power” registry, focused on RA, psoriasis, and psoriatic arthritis. He also leads the multi-center NIH-funded large pragmatic randomized controlled trial “VERVE” studying the safety and effectiveness of the live herpes zoster vaccine in patients receiving biologic agents. He is a member of the Center for Disease Control (CDC) Advisory Committee on Immunization Practices (ACIP) Herpes Zoster workgroup. In 2015, he was appointed as a member to the FDA Arthritis Advisory Committee. Dr. Curtis also studies risk factors for and outcomes of osteoporosis. He was a member of the ACR’s task force to update recommendations for the management of glucocorticoid induced osteoporosis (GIOP). He served on the ASBMR Task Force on Atypical Subtrochanteric and Diaphyseal Fractures. Dr. Curtis is a member of the American College of Rheumatology (ACR), the International Society for Pharmacoepidemiology (ISPE), the American Medical Informatics Association (AMIA), and the American Society of Bone and Mineral Research (ASBMR). He has been on the editorial board for Arthritis & Rheumatism, Pharmacoepidemiology and Drug Safety (PDS) and Arthritis Care and Research (AC&R). He has authored more than 400 peer-reviewed manuscripts, review articles and book chapters.
  • Selected Publications

    Academic Article

    Year Title Altmetric
    2019 Data linkages between patient-powered research networks and health plans: a foundation for collaborative research. 2019
    2019 The promise and perils of 'Big Data': focus on spondyloarthritis 2019
    2019 A Flexible Open-Source Decision Model for Value Assessment of Biologic Treatment for Rheumatoid Arthritis 2019
    2019 Adjustment of the multi-biomarker disease activity score to account for age, sex and adiposity in patients with rheumatoid arthritis 2019
    2019 Digital Interventions to Build a Patient Registry for Rheumatology Research 2019
    2019 Long-term safety of certolizumab pegol in rheumatoid arthritis, axial spondyloarthritis, psoriatic arthritis, psoriasis and Crohn's disease: A pooled analysis of 11 317 patients across clinical trials 2019
    2019 Opioid use in rheumatoid arthritis: trends, efficacy, safety, and best practices 2019
    2019 The Interface Between Digital Health and Rheumatology 2019
    2019 Tools and Methods for Real-World Evidence Generation: Pragmatic Trials, Electronic Consent, and Data Linkages 2019
    2019 Toward relevant and credible cost-effectiveness analyses for value assessment in the decentralized U.S. health care system 2019
    2019 Comparative risks of chronic inhaled corticosteroids and macrolides for bronchiectasis. 2019
    2019 Improved Quality of Life With Anti-TNF Therapy Compared With Continued Corticosteroid Utilization in Crohn's Disease. 2019
    2019 Patient attitudes about non-medical switching to biosimilars: results from an online patient survey in the United States 2019
    2019 Physician attitudes about non-medical switching to biosimilars: results from an online physician survey in the United States 2019
    2019 Uptake and Clinical Utility of Multibiomarker Disease Activity Testing in the United States. 2019
    2019 PROMIS Fatigue short forms are reliable and valid in adults with rheumatoid arthritis. 2019
    2019 Risk of subsequent fracture after prior fracture among older women 2019
    2019 Direct-acting antivirals for hepatitis C: Predictors of early discontinuation in the real world 2019
    2019 Immunosuppressive treatment and the risk of diabetes in rheumatoid arthritis 2019
    2019 Predicting risk for radiographic damage in rheumatoid arthritis: comparative analysis of the multi-biomarker disease activity score and conventional measures of disease activity in multiple studies 2019
    2019 Predictors of achieving remission among patients with psoriatic arthritis initiating a tumor necrosis factor inhibitor 2019
    2018 Importance of Recent Fracture as Predictor of Imminent Fracture Risk 2018
    2018 Anti-TNF and Physiologic Measures of Metabolic Disease in Rheumatoid Arthritis. 2018
    2018 Correction to: Hip fracture trends in the United States, 2002 to 2015 (Osteoporosis International, (2018), 29, 3, (717-722), 10.1007/s00198-017-4345-0) 2018
    2018 Glucocorticoid Exposure and Fracture Risk in a Cohort of US Patients With Selected Conditions 2018
    2018 Patient Governance in a Patient-Powered Research Network for Adult Rheumatologic Conditions 2018
    2018 Combining online and in-person methods to evaluate the content validity of PROMIS fatigue short forms in rheumatoid arthritis 2018
    2018 Opioids vs nonopioids for chronic back, hip, or knee pain 2018
    2018 An Observational Study of Cardiovascular Risks Associated with Rheumatoid Arthritis Therapies: A Comparison of Two Analytical Approaches 2018
    2018 Gastrointestinal Perforations with Biologics in Patients with Rheumatoid Arthritis: Implications for Clinicians 2018
    2018 Satisfaction with Subcutaneous Golimumab and its Auto-Injector among Rheumatoid Arthritis Patients with Inadequate Response to Adalimumab or Etanercept 2018
    2018 Worldwide, 3-Year, Post-Marketing Surveillance Experience with Tofacitinib in Rheumatoid Arthritis. 2018
    2018 Evaluation of a Multimodal, Direct-to-Patient Educational Intervention Targeting Barriers to Osteoporosis Care: A Randomized Clinical Trial 2018
    2018 Obesity and response to anti-tumor necrosis factor-α agents in patients with select immune-mediated inflammatory diseases: A systematic review and meta-analysis 2018
    2018 Use of Scribes for Documentation Assistance in Rheumatology and Endocrinology Clinics: Impact on Clinic Workflow and Patient and Physician Satisfaction 2018
    2018 Hip fracture trends in the United States, 2002 to 2015 2018
    2018 Advancing the Science and Practice of Medication Adherence 2018
    2018 Influence of obesity, age, and comorbidities on the multi-biomarker disease activity test in rheumatoid arthritis 2018
    2018 Just the FRAX: Management of Glucocorticoid-Induced Osteoporosis 2018
    2018 Assessing a novel way to measure step count while walking using a custom mobile phone application 2018
    2018 Development of algorithms for identifying fatal cardiovascular disease in Medicare claims 2018
    2018 Lipid management among individuals with inflammatory arthritis in the national REasons for geographic and racial differences in stroke (REGARDS) cohort 2018
    2018 Routine use of quantitative disease activity measurements among us rheumatologists: Implications for treat-to-target management strategies in rheumatoid arthritis 2018
    2017 Studies with herpes zoster vaccines in immune compromised patients 2017
    2017 Critical outcomes in longitudinal observational studies and registries in patients with rheumatoid arthritis: An OMERACT special interest group report 2017
    2017 The cost of a patient activation intervention for achieving successful outcomes: results from the PAADRN randomized controlled trial 2017
    2017 The effects of a patient activation intervention on smoking and excessive drinking cessations: results from the PAADRN randomized controlled trial 2017
    2017 Stakeholders' views on data sharing in multicenter studies 2017
    2017 Erratum to: Assessing the feasibility of the Effectiveness of Discontinuing Bisphosphonates trial: a pilot study (Osteoporosis International, (2017), 28, 8, (2495-2503), 10.1007/s00198-017-4073-5) 2017
    2017 Longterm effectiveness of herpes zoster vaccine among patients with autoimmune and inflammatory diseases 2017
    2017 Assessing the feasibility of the Effectiveness of Discontinuing Bisphosphonates trial: a pilot study 2017
    2017 Outcomes of tumor necrosis factor inhibitor cycling versus switching to a disease-modifying anti-rheumatic drug with a new mechanism of action among patients with rheumatoid arthritis 2017
    2017 Safety of biologic and nonbiologic disease-modifying antirheumatic drug therapy in veterans with rheumatoid arthritis and hepatitis c virus infection 2017
    2017 Improving medical record retrieval for validation studies in Medicare data 2017
    2017 The clinical status and economic savings associated with remission among patients with rheumatoid arthritis: leveraging linked registry and claims data for synergistic insights 2017
    2017 Association of 3 different antihypertensive medications with hip and pelvic fracture risk in older adults secondary analysis of a randomized clinical trial 2017
    2016 A multi-modal intervention for Activating Patients at Risk for Osteoporosis (APROPOS): Rationale, design, and uptake of online study intervention material 2016
    2016 Head-to-head comparison of certolizumab pegol versus adalimumab in rheumatoid arthritis: 2-year efficacy and safety results from the randomised EXXELERATE study 2016
    2016 Population Variations in Rheumatoid Arthritis Treatment and Outcomes, Northern California, 1998-2009 2016
    2016 Adherence and persistence with methotrexate in rheumatoid arthritis: A systematic review 2016
    2016 Glucocorticoid exposure and fracture risk in patients with new-onset rheumatoid arthritis 2016
    2016 Analysis of health care claims during the peri-transfer stage of transition from pediatric to adult care among juvenile idiopathic arthritis patients 2016
    2016 Diagnostic Prevalence of Ankylosing Spondylitis Using Computerized Health Care Data, 1996 to 2009: Underrecognition in a US Health Care Setting 2016
    2016 Rationale and design of the randomized evaluation of an Ambulatory Care Pharmacist-Led Intervention to Optimize Urate Lowering Pathways (RAmP-UP) Study 2016
    2016 A pragmatic randomized trial comparing tablet computer informed consent to traditional paper-based methods for an osteoporosis study 2016
    2016 What Proportion of Incident Radiographic Vertebral Fractures in Older Men Is Clinically Diagnosed and Vice Versa: A Prospective Study 2016
    2016 Agreement between Medicare pharmacy claims, self-report, and medication inventory for assessing lipid-lowering medication use 2016
    2016 Agreement between rheumatologist and patient-reported adherence to methotrexate in a US rheumatoid arthritis registry 2016
    2016 Dosing of Intravenous Tocilizumab in a Real-World Setting of Rheumatoid Arthritis: Analyses from the Corrona Registry. 2016
    2016 Reenergizing Research While Improving Patient Care 2016
    2016 Comparative effectiveness of etanercept and adalimumab in patient reported outcomes and injection-related tolerability 2016
    2016 Risk of nonmelanoma skin cancer associated with the use of immunosuppressant and biologic agents in patients with a history of autoimmune disease and nonmelanoma skin cancer 2016
    2016 Risk of Cardiovascular Outcomes among Psoriasis Patients Treated with Biologics and Other Systemic Agents. 2016
    2015 The Risk for Cardiovascular Events Associated with Hyperlipdemia among Patients with and Without Rheumatoid Arthritis. 2015
    2015 Bone mineral density as a predictor of subsequent wrist fractures: Findings from the women's health initiative study 2015
    2015 Effectiveness and costs of biologics in veterans with rheumatoid arthritis 2015
    2015 Methotrexate Adherence Questionnaire: a New Tool to Assess Adherence in Patients Treated with Methotrexate. 2015
    2015 Wrist Fracture and Risk of Subsequent Fracture: Findings from the Women's Health Initiative Study 2015
    2015 Heterogeneous disease trajectories explain variable radiographic, function and quality of life outcomes in the Canadian Early Arthritis Cohort (CATCH) 2015
    2015 The validity of claims-based algorithms to identify serious hypersensitivity reactions and osteonecrosis of the jaw 2015
    2015 An internet-based controlled trial aimed to improve osteoporosis prevention among chronic glucocorticoid users 2015
    2015 Cost and effectiveness of biologics for rheumatoid arthritis in a commercially insured population 2015
    2015 DXA utilization between 2006 and 2012 in commercially insured younger postmenopausal women 2015
    2015 Modifiable factors associated with allopurinol adherence and outcomes among patients with gout in an integrated healthcare system 2015
    2015 Tocilizumab in rheumatoid arthritis: A case study of safety evaluations of a large postmarketing data set from multiple data sources 2015
    2014 The association between inflammatory markers, serum lipids and the risk of cardiovascular events in patients with rheumatoid arthritis 2014
    2014 The recent prevalence of osteoporosis and low bone mass in the United States based on bone mineral density at the femoral neck or lumbar spine 2014
    2014 Persistence and dose escalation of tumor necrosis factor inhibitors in US veterans with rheumatoid arthritis 2014
    2014 Recent trends in medication usage for the treatment of juvenile idiopathic arthritis and the influence of tumor necrosis factor inhibitors 2014
    2014 Death, debility, and destitution following hip fracture 2014
    2014 Comparative cancer risk associated with methotrexate, other non-biologic and biologic disease-modifying anti-rheumatic drugs 2014
    2014 Continued benefit of tocilizumab plus disease-modifying antirheumatic drug therapy in patients with rheumatoid arthritis and inadequate clinical responses by week 8 of treatment 2014
    2014 Genetic variants associated with methotrexate efficacy and toxicity in early rheumatoid arthritis: Results from the treatment of early aggressive rheumatoid arthritis trial 2014
    2014 High plasma levels of vitamin C and E are associated with incident radiographic knee osteoarthritis 2014
    2014 An evaluation of clinical risk factors for estimating fracture risk in postmenopausal osteoporosis using an electronic medical record database 2014
    2014 Atypical subtrochanteric and diaphyseal femoral fractures: Second report of a task force of the American society for bone and mineral research 2014
    2014 Bisphosphonates and hip and nontraumatic subtrochanteric femoral fractures in the veterans health administration 2014
    2014 Effect of self-referral on bone mineral density testing and osteoporosis treatment 2014
    2014 Initiation of TNF inhibitor therapy and change in physiologic measures in psoriasis 2014
    2014 International management of bone health in glucocorticoid-exposed individuals in the observational GLOW study 2014
    2014 Safety and efficacy of tofacitinib, an oral janus kinase inhibitor, for the treatment of rheumatoid arthritis in open-Label, longterm extension studies 2014
    2014 Trends in the utilization and outcomes of medicare patients hospitalized for hip fracture, 2000-2008 2014
    2014 Use of a validated algorithm to estimate the annual cost of effective biologic treatment for rheumatoid arthritis 2014
    2014 Use of pharmacologic agents for the primary prevention of osteoporosis among older women with low bone mass 2014
    2014 Vaccinations for rheumatoid arthritis 2014
    2013 Commentary: Measuring quality of care in osteoporosis 2013
    2013 Commentary: The five ws of a fracture liaison service: Why, who, what, where, and how? in osteoporosis, we reap what we sow 2013
    2013 Epidemiologic research of invasive fungal infections using large healthcare databases 2013
    2013 Using registries to identify adverse events in rheumatic diseases 2013
    2013 Challenges in defining quality of care for glucocorticoid-induced osteoporosis: Defending good against perfect 2013
    2013 Design and methods of a postmarketing pharmacoepidemiology study assessing long-term safety of Prolia ® (denosumab) for the treatment of postmenopausal osteoporosis 2013
    2013 Multimodal intervention to improve osteoporosis care in home health settings: Results from a cluster randomized trial 2013
    2013 Predictors and persistence of new-onset clinical remission in rheumatoid arthritis patients 2013
    2013 Identifying newly approved medications in Medicare claims data: A case study using tocilizumab 2013
    2013 Validity of diagnostic codes and prevalence of psoriasis and psoriatic arthritis in a managed care population, 1996-2009 2013
    2013 Incidence and prevalence of juvenile idiopathic arthritis among children in a managed care population, 1996-2009 2013
    2013 Clinical response within 12 weeks as a predictor of future low disease activity in patients with early RA: Results from the TEAR trial 2013
    2013 New methods for determining comparative effectiveness in rheumatoid arthritis 2013
    2013 Newest clinical trial results with antitumor necrosis factor and nonantitumor necrosis factor biologics for rheumatoid arthritis 2013
    2013 Development of a Multi-Biomarker Disease Activity Test for Rheumatoid Arthritis 2013
    2013 A close examination of healthcare expenditures related to fractures 2013
    2013 Association between anti-TNF-α therapy and interstitial lung disease 2013
    2013 Performance of FRAX in a cohort of community-dwelling, ambulatory older men: The Osteoporotic Fractures in Men (MrOS) study 2013
    2013 Association between the initiation of anti-tumor necrosis factor therapy and the risk of herpes zoster 2013
    2013 Magnitude and consequences of misclassification of incident hip fractures in large cohort studies: The Study of Osteoporotic Fractures and Medicare claims data 2013
    2013 Comparative effectiveness of nonbiologic versus biologic disease-modifying antirheumatic drugs for rheumatoid arthritis 2013
    2013 Generic alendronate use among medicare beneficiaries: Are part d data complete? 2013
    2013 The PAADRN Study: A design for a randomized controlled practical clinical trial to improve bone health 2013
    2013 Using tablet computers compared to interactive voice response to improve subject recruitment in osteoporosis pragmatic clinical trials: Feasibility, satisfaction, and sample size 2013
    2012 A randomized trial of a mailed intervention and self-scheduling to improve osteoporosis screening in postmenopausal women 2012
    2012 Association between anti-TNF-α therapy and all-cause mortality 2012
    2012 Improving the efficiency and effectiveness of pragmatic clinical trials in older adults in the United States 2012
    2012 Recent trends in hip fracture rates by race/ethnicity among older US adults 2012
    2012 Postherpetic neuralgia after herpes zoster vaccination - Reply 2012
    2012 Defining physiologically "normal" vitamin D in African Americans 2012
    2012 Association between Vaccination for Herpes Zoster and Risk of Herpes Zoster Infection among Older Patients with Selected Immune-Mediated Diseases 2012
    2012 Management of osteoporosis among the elderly with other chronic medical conditions 2012
    2012 Timing and magnitude of initial change in disease activity score 28 predicts the likelihood of achieving low disease activity at 1 year in rheumatoid arthritis patients treated with certolizumab pegol: A post-hoc analysis of the RAPID 1 trial 2012
    2012 Association of intact parathyroid hormone levels with subsequent hip BMD loss: The Osteoporotic Fractures in Men (MrOS) study 2012
    2012 Comparative safety of infliximab and etanercept on the risk of serious infections: Does the association vary by patient characteristics? 2012
    2012 Central DXA utilization shifts from office-based to hospital-based settings among medicare beneficiaries in the wake of reimbursement changes 2012
    2012 In response 2012
    2012 Evaluating comorbidity scores based on health service expenditures 2012
    2012 Improving osteoporosis care in high-risk home health patients through a high-intensity intervention 2012
    2012 Validation of Diagnostic Codes for Subtrochanteric, Diaphyseal, and Atypical Femoral Fractures Using Administrative Claims Data 2012
    2011 Initiation of tumor necrosis factor-αantagonists and the risk of hospitalization for infection in patients with autoimmune diseases 2011
    2011 Retreatment with rituximab based on a treatment-to-target approach provides better disease control than treatment as needed in patients with rheumatoid arthritis: A retrospective pooled analysis 2011
    2011 Study design for a comprehensive assessment of biologic safety using multiple healthcare data systems 2011
    2011 Validation of ICD-9-CM codes to identify gastrointestinal perforation events in administrative claims data among hospitalized rheumatoid arthritis patients 2011
    2011 Geographic distribution of endemic fungal infections among older persons, United States 2011
    2011 Developing a construct to evaluate flares in rheumatoid arthritis: A conceptual report of the OMERACT RA Flare Definition Working Group 2011
    2011 Erratum: Atypical subtrochanteric and diaphyseal femoral fractures: Report of a task force of the American Society for Bone and Mineral Research (Journal of Bone and Mineral Research (2010) 25 (2267-2294)) 2011
    2011 Improving osteoporosis care through multimodal interventions: Insights from the University of Alabama at Birmingham Center for Education and Research on Therapeutics 2011
    2011 Consistency of knee pain and risk of knee replacement: The multicenter osteoarthritis study 2011
    2011 Official Positions for FRAX® Clinical Regarding International Differences. From Joint Official Positions Development Conference of the International Society for Clinical Densitometry and International Osteoporosis Foundation on FRAX® 2011
    2011 Medical costs of osteoporosis in the elderly Medicare population 2011
    2011 Rapid improvement in the signs and symptoms of rheumatoid arthritis following certolizumab pegol treatment predicts better longterm outcomes: Post-hoc analysis of a randomized controlled trial 2011
    2011 Placebo adherence, clinical outcomes, and mortality in the women's health initiative randomized hormone therapy trials 2011
    2011 Response to Letter to Editor on validation study identifying bacterial infections in rheumatoid arthritis patients 2011
    2011 Clinical and demographic factors associated with fractures among older Americans 2011
    2011 Erratum: Clinical and demographic factors associated with fractures among older Americans (Osteoporosis International DOI: 10.1007/s00198-010-1300-8) 2011
    2011 The relationship between bisphosphonate adherence and fracture: Is it the behavior or the medication? Results from the placebo arm of the fracture intervention trial 2011
    2011 TNF-α antagonist use and risk of hospitalization for infection in a national cohort of veterans with rheumatoid arthritis 2011
    2011 Injection-site burning and stinging in patients with rheumatoid arthritis using injectable biologics 2011
    2011 Which fractures are most attributable to osteoporosis? 2011
    2010 Atypical subtrochanteric and diaphyseal femoral fractures: Report of a task force of the american society for bone and mineral Research 2010
    2010 Consistency of knee pain: Correlates and association with function 2010
    2010 Osteoporosis care in the United States after declines in reimbursements for DXA 2010
    2010 Cost-effectiveness of multifaceted evidence implementation programs for the prevention of glucocorticoid-induced osteoporosis 2010
    2010 Health services utilization after fractures: Evidence from Medicare 2010
    2010 Estimates of the proportion of older white men who would be recommended for pharmacologic treatment by the new US national osteoporosis foundation guidelines 2010
    2010 Identifying types of nursing facility stays using medicare claims data: An algorithm and validation 2010
    2010 Privacy-maintaining propensity score-based pooling of multiple databases applied to a study of biologics 2010
    2010 Bisphosphonate-associated osteonecrosis of the jaw, with healing after teriparatide: A review of the literature and a case report 2010
    2010 Pre-radiographic MRI findings are associated with onset of knee symptoms: the most study 2010
    2010 Vitamin D status and its associations with disease activity and severity in african americans with recent-onset rheumatoid arthritis 2010
    2010 A Comparison of Patient Characteristics and Outcomes in Selected European and U.S. Rheumatoid Arthritis Registries1 2010
    2010 Is withholding osteoporosis medication after fracture sometimes rational? A Comparison of the risk for second fracture versus death 2010
    2009 Health care expenditures associated with skeletal fractures among medicare beneficiaries, 1999-2005 2009
    2009 "pathologic" fractures: Should these be included in epidemiologic studies of osteoporotic fractures? 2009
    2009 Do physicians within the same practice setting manage osteoporosis patients similarly? Implications for implementation research 2009
    2009 Quality health care gaps in osteoporosis: How can patients, providers, and the health system do a better job? 2009
    2009 Systemic Nonarticular Manifestations of Rheumatoid Arthritis: Focus on Inflammatory Mechanisms 2009
    2009 Estimated prevalence and patterns of presumed osteoporosis among older Americans based on Medicare data 2009
    2009 The geographic availability and associated utilization of dual-energy X-ray absorptiometry (DXA) testing among older persons in the United States 2009
    2009 Adherence to osteoporosis treatments: Room for improvement 2009
    2009 RisedronatE and ALendronate intervention over three years (REALITY): Minimal differences in fracture risk reduction 2009
    2009 Vertebroplasty and kyphoplasty are associated with an increased risk of secondary vertebral compression fractures: A population-based cohort study 2009
    2009 Management of osteoporosis among home health and long-term care patients with a prior fracture 2009
    2009 Improving the prediction of medication compliance: The example of bisphosphonates for osteoporosis 2009
    2009 Administrative codes combined with medical records based criteria accurately identified bacterial infections among rheumatoid arthritis patients 2009
    2009 Bridging the osteoporosis quality chasm 2009
    2009 Identification and validation of vertebral compression fractures using administrative claims data 2009
    2009 Population-based fracture risk assessment and osteoporosis treatment disparities by race and gender 2009
    2009 Validity of physician-reported hospitalized infections in a US arthritis registry. 2009
    2008 Tumor necrosis factor inhibitors and infection complications 2008
    2008 Risk of hip fracture after bisphosphonate discontinuation: Implications for a drug holiday 2008
    2008 Muscle Mass Is More Strongly Related to Hip Bone Mineral Density Than Is Quadriceps Strength or Lower Activity Level in Adults Over Age 50 Year 2008
    2008 Regional Variation in the Denial of Reimbursement for Bone Mineral Density Testing Among US Medicare Beneficiaries 2008
    2008 Adaptation of bayesian data mining algorithms to longitudinal claims data: Coxib safety as an example 2008
    2008 Benefit of adherence with bisphosphonates depends on age and fracture type: Results from an analysis of 101,038 new bisphosphonate users 2008
    2008 Longitudinal trends in use of bone mass measurement among older Americans, 1999-2005 2008
    2008 Association of infections and tuberculosis with antitumor necrosis factor alpha therapy 2008
    2008 Biologics and heart failure in rheumatoid arthritis: Are we any wiser? 2008
    2008 Improving quality of care in osteoporosis: Opportunities and challenges 2008
    2008 The epidemiology of glucocorticoid-associated adverse events 2008
    2007 Heart failure among younger rheumatoid arthritis and Crohn's patients exposed to TNF-α antagonists 2007
    2007 Prevalence and predictors of osteoporosis treatment in nursing home residents with known osteoporosis or recent fracture 2007
    2007 Prevention and treatment of glucocorticoid-induced osteoporosis 2007
    2006 Agreement and validity of pharmacy data versus self-report for use of osteoporosis medications among chronic glucocorticoid users 2006
    2006 Channeling and adherence with alendronate and risedronate among chronic glucocorticoid users 2006
    2006 Trends in prevention of glucocorticoid-induced osteoporosis 2006
    2006 Medication errors with the use of allopurinol and colchicine: A retrospective study of a national, anonymous internet-accessible error reporting system 2006
    2006 Documented tuberculin skin testing among infliximab users following a multi-modal risk communication interventions 2006
    2005 Prevalence of osteoporosis and osteopenia among African Americans with early rheumatoid arthritis: The impact of ethnic-specific normative data 2005
    2004 Swallowing difficulties from "DISH-phagia" 2004
    2004 Evaluating and improving the quality of care in rheumatic disease 2004
    2003 Nonsteroidal Antiinflammatory Drug Toxicity Monitoring and Safety Practices 2003
    2003 The Use of Glucocorticoids in Arthritis – 20 Clinical Pearls 2003

    Chapter

    Year Title Altmetric
    2018 Studies of Biologicals 2018
    2009 Bisphosphonate Therapy for Osteoporosis 2009
    2008 Glucocorticoid-Induced Osteoporosis.  1135-1166. 2008
    2005 Prevention and Treatment 2005
    2004 Therapeutic Dictionary of Rheumatology and Immunology 2004
    2001 Glucocorticoid-induced osteoporosis.  140-145. 2001
    2000 New Biologics: Cytokines 2000

    Research Overview

  • Rheumatoid Arthritis
    Psoriatic Arthritis
    Ankylosing Spondylitis
    Osteoporosis
  • Principal Investigator On

  • Private Grant  awarded by AMGEN, INC. 2011 - 2024
  • Private Grant  awarded by JANSSEN RESEARCH & DEVELOPMENT, LLC 2016 - 2021
  • Harnessing PCORnet to Study Comparative Effectiveness and Safety of Biologic Therapies  awarded by PATIENT CENTERED OUTCOMES RESEARCH INSTITUTE 2016 - 2020
  • Private Grant  awarded by CRESCENDO BIOSCIENCE, INC. 2018 - 2020
  • Private Grant  awarded by AMGEN, INC. 2015 - 2020
  • Private Grant  awarded by CRESCENDO BIOSCIENCE, INC. 2018 - 2020
  • Private Grant  awarded by CRESCENDO BIOSCIENCE, INC. 2015 - 2019
  • Safety and Effectiveness of Live Zoster Vaccine in Anti-TNF Users (VERVE Trial)  awarded by National Institute of Arthritis & Musculoskeletal & Skin Diseases/NIH/DHHS 2014 - 2019
  • Arthritis Patient Partnership with Comparative Effectiveness Researchers (Arthritis Patient PoWER)  awarded by GLOBAL HEALTHY LIVING FOUNDATION 2015 - 2019
  • UAB Multidisciplinary Clinical Research Center - Project 2: Facilitating Treat-to-Target Using Novel Health Technology with Decision Support  awarded by National Institute of Arthritis & Musculoskeletal & Skin Diseases/NIH/DHHS 2013 - 2019
  • Treatments Against RA and Effect of FDG PET-CT: The TARGET Trial  awarded by Brigham and Women's Hospital 2015 - 2019
  • Private Grant  awarded by BRISTOL MYERS SQUIBB PHARMACEUTICAL COMPANY 2017 - 2019
  • Private Grant  awarded by BRISTOL MYERS SQUIBB PHARMACEUTICAL COMPANY 2016 - 2019
  • Private Grant  awarded by RADIUS HEALTH 2018 - 2019
  • Private Grant  awarded by Genentech 2014 - 2019
  • Enhancing Patient Ability to Understand and Utilize Complex Information Concerning Medication Self-Management  awarded by University of North Carolina at Chapel Hill 2016 - 2018
  • Private Grant  awarded by Pfizer Inc., U.S. Pharmaceuticals Group 2014 - 2018
  • Private Grant  awarded by Pfizer Inc., U.S. Pharmaceuticals Group 2017 - 2018
  • Comparative Effectiveness and Safety of Inhaled Corticosteroids and Antimicrobial Compounds for Non-CF Bronchiectasis  awarded by Oregon Health & Science University 2016 - 2018
  • Privacy-Preserving Analytic and Data-Sharing Methods for Clinical and Patient-Powered Research Data Research Networks  awarded by HARVARD PILGRIM HEALTH CARE 2015 - 2017
  • Private Grant  awarded by JANSSEN RESEARCH & DEVELOPMENT, LLC 2014 - 2017
  • Private Grant  awarded by Pfizer Pharmaceuticals 2009 - 2017
  • Centers of Research Translation (CoRT) - Project 4  awarded by National Institute of Arthritis & Musculoskeletal & Skin Diseases/NIH/DHHS 2012 - 2017
  • Private Grant  awarded by CELGENE CORPORATION 2010 - 2017
  • Private Grant  awarded by Pfizer Pharmaceuticals 2014 - 2017
  • Making PROMISE Meaningful to Patients and Providers in Clinical Practice  awarded by Johns Hopkins University 2015 - 2016
  • Private Grant  awarded by Pfizer Inc., U.S. Pharmaceuticals Group 2013 - 2016
  • Patient Valued Comparative Effectiveness of Corticosteroids Versus Anti-TNF Alpha Therapy for Inflammatory Bowel Disease  awarded by University of Pennsylvania 2013 - 2016
  • Private Grant  awarded by F.Hoffmann-La Roche Ltd. 2012 - 2016
  • Private Grant  awarded by AMGEN, INC. 2014 - 2016
  • A Pilot Study of the Safety and Effectiveness of the Live Zoster Vaccine in Anti-TNF Users  awarded by RHEUMATOLOGY RESEARCH FOUNDATION 2013 - 2016
  • Private Grant  awarded by CONSORTIUM OF RHEUMATOLOGY RESEARCHERS OF NORTH AMERICA, INC. 2008 - 2016
  • Private Grant  awarded by Pfizer Inc., U.S. Pharmaceuticals Group 2014 - 2016
  • Private Grant  awarded by Pfizer Inc., U.S. Pharmaceuticals Group 2012 - 2016
  • Private Grant  awarded by AMGEN, INC. 2014 - 2015
  • Private Grant  awarded by AMGEN, INC. 2012 - 2015
  • Private Grant  awarded by KNOLL PHARMACEUTICAL COMPANY 2007 - 2015
  • Private Grant  awarded by JANSSEN RESEARCH & DEVELOPMENT, LLC 2012 - 2015
  • Arthritis Patient Partnership With Comparative Effectiveness Researchers (AR-Power PPRN)  awarded by GLOBAL HEALTHY LIVING FOUNDATION 2014 - 2015
  • Private Grant  awarded by REGENERON PHARMACEUTICALS, INC. 2014 - 2015
  • Private Grant  awarded by UCB, INC. 2012 - 2015
  • Private Grant  awarded by Sanofi US Services Inc 2013 - 2015
  • Private Grant  awarded by Pfizer Pharmaceuticals 2013 - 2015
  • Private Grant  awarded by UCB, INC. 2012 - 2014
  • Longitudinal Comparative Effectiveness & Safety of Biologics in Autoimmunity  awarded by Agency for Healthcare Research and Quality/DHHS 2009 - 2014
  • Private Grant  awarded by Genentech 2012 - 2014
  • Private Grant  awarded by AMGEN, INC. 2014
  • Private Grant  awarded by Genentech 2007 - 2014
  • Private Grant  awarded by Pfizer Pharmaceuticals 2010 - 2014
  • Private Grant  awarded by INCYTE CORPORATION 2009 - 2014
  • Private Grant  awarded by ELI LILLY AND COMPANY 2011 - 2014
  • Private Grant  awarded by Pfizer Inc., U.S. Pharmaceuticals Group 2012 - 2014
  • Private Grant  awarded by Genentech 2011 - 2013
  • Private Grant  awarded by ASTRAZENECA PHARMACEUTICALS LP 2011 - 2013
  • Private Grant  awarded by Genentech 2011 - 2013
  • Private Grant  awarded by ACTURIAL RESEARCH CORPORATION 2013
  • Private Grant  awarded by Sanofi US Services Inc 2010 - 2013
  • Private Grant  awarded by ANOLINX, LLC 2011 - 2013
  • Private Grant  awarded by CONSORTIUM OF RHEUMATOLOGY RESEARCHERS OF NORTH AMERICA, INC. 2007 - 2013
  • Private Grant  awarded by Genentech 2012 - 2013
  • ACE Protocol #ARA06  awarded by Duke University 2009 - 2013
  • Private Grant  awarded by F.Hoffmann-La Roche Ltd. 2007 - 2013
  • Private Grant  awarded by ELI LILLY AND COMPANY 2008 - 2013
  • Private Grant  awarded by UCB PHARMA, INC. 2011 - 2013
  • Private Grant  awarded by BRISTOL MYERS SQUIBB PHARMACEUTICAL COMPANY 2010 - 2013
  • Private Grant  awarded by Genentech 2011 - 2013
  • Private Grant  awarded by REGENERON PHARMACEUTICALS, INC. 2008 - 2013
  • Private Grant  awarded by Centocor 2007 - 2013
  • Private Grant  awarded by UCB PHARMA, INC. 2011 - 2012
  • Coronary Heart Disease in Rheumatoid Arthritis  awarded by Arthritis Foundation 2011 - 2012
  • The TAKEOFF Trial: Clinical Trial Planning Grant  awarded by National Institute of Arthritis & Musculoskeletal & Skin Diseases/NIH/DHHS 2011 - 2012
  • Ethnic Differences in the Risk of Fracture and Vascular Disease  awarded by National Institute of Arthritis & Musculoskeletal & Skin Diseases/NIH/DHHS 2007 - 2012
  • Private Grant  awarded by F.Hoffmann-La Roche Ltd. 2007 - 2012
  • Private Grant  awarded by Pfizer Pharmaceuticals 2009 - 2012
  • Safety and Effectiveness of Herpes Zoster Vaccination in Rheumatoid Arthritis Patients  awarded by American College of Rheumatology 2011 - 2012
  • Private Grant  awarded by Genentech 2008 - 2012
  • Private Grant  awarded by F.Hoffmann-La Roche Ltd. 2010 - 2012
  • Private Grant  awarded by Genentech 2009 - 2012
  • Long Term Risks and Extra-Skeletal Benefits of Biologics  awarded by Duke (Doris) Charitable Foundation 2007 - 2012
  • Private Grant  awarded by Sanofi US Services Inc 2010 - 2011
  • Private Grant  awarded by Sanofi US Services Inc 2010 - 2011
  • Private Grant  awarded by AMGEN, INC. 2007 - 2011
  • Kaiser Permanente Autoimmune Disease Registry  awarded by Kaiser Permanente 2009 - 2011
  • Private Grant  awarded by F.Hoffmann-La Roche Ltd. 2009 - 2011
  • Private Grant  awarded by UCB PHARMA, INC. 2008 - 2011
  • Private Grant  awarded by F.Hoffmann-La Roche Ltd. 2007 - 2011
  • Private Grant  awarded by ABBOTT LABORATORIES 2007 - 2011
  • Private Grant  awarded by WYETH PHARMACEUTICALS, INC. 2008 - 2011
  • ACE - Switching Anti-TNF-a Agents in Patients with RA with an Inadequate Response to TNF-a Inhibition - ACE  awarded by Duke University 2009 - 2011
  • Private Grant  awarded by CRESCENDO BIOSCIENCE, INC. 2009 - 2010
  • Arthritis Foundation Investigator Award: Osteoporosis and Associated Stroke and MI in a Multi-Ethnic Cohort  awarded by Arthritis Foundation 2007 - 2010
  • Private Grant  awarded by AMGEN, INC. 2009 - 2010
  • Private Grant  awarded by Genentech 2007 - 2010
  • Investigator On

  • INvestigations In Gout, Hyperuricemia, and ComorbidiTies (INSIGHT) Center of Research Translation (CORT)  awarded by National Institute of Arthritis & Musculoskeletal & Skin Diseases/NIH/DHHS 2017 - 2022
  • INvestigations In Gout, Hyperuricemia, and ComorbidiTies (INSIGHT) Center of Research Translation (CORT) - Administrative Core  awarded by National Institute of Arthritis & Musculoskeletal & Skin Diseases/NIH/DHHS 2017 - 2022
  • Strengthening Translational Research in Diverse Enrollment (STRIDE)  awarded by UNIVERSITY OF MASSACHUSETTS (WORCESTER) 2016 - 2021
  • Multimorbidity in Rheumatoid Arthritis  awarded by American College of Rheumatology 2019 - 2020
  • National Resource Center for High-Impact Clinical Trials in Medical Rehabilitation: Promo/Dissemination Component  awarded by National Institute of Child Health and Human Development/NIH/DHHS 2015 - 2020
  • National Resource Center for High-Impact Clinical Trials in Medical Rehabilitation: Tech Developments Component  awarded by National Institute of Child Health and Human Development/NIH/DHHS 2015 - 2020
  • Rehabilitation Research Resource to Enhance Clinical Trials (REACT)  awarded by National Institute of Child Health and Human Development/NIH/DHHS 2015 - 2020
  • The Relationship of Disease Activity to Medication use in the RISE Registry  awarded by American College of Rheumatology 2017 - 2019
  • Private Grant  awarded by Pfizer Inc., U.S. Pharmaceuticals Group 2016 - 2019
  • Private Grant  awarded by BRISTOL MYERS SQUIBB PHARMACEUTICAL COMPANY 2017 - 2019
  • UAB Multidisciplinary Clinical Research Center (P60)  awarded by National Institute of Arthritis & Musculoskeletal & Skin Diseases/NIH/DHHS 2013 - 2019
  • ACE Protocol ARA08: Strategy to Prevent the Onset of Clinically-Apparent Rheumatoid Arthritis (StopRA)  awarded by University of California, San Francisco 2015 - 2019
  • Private Grant  awarded by ASTRAZENECA PHARMACEUTICALS LP 2016 - 2019
  • Outliers - Extreme Long-term Survivors with Metastatic Breast Cancer  awarded by University of Wisconsin-Madison 2018
  • Brain Thermometry: A Non-Invasive Method for Detecting Neuroinflammation in RA  awarded by RHEUMATOLOGY RESEARCH FOUNDATION 2016 - 2017
  • Centers of Research Translation (CoRT)  awarded by National Institute of Arthritis & Musculoskeletal & Skin Diseases/NIH/DHHS 2012 - 2017
  • UAB Deep South Arthritis and Musculoskeletal CERTs  awarded by Agency for Healthcare Research and Quality/DHHS 2011 - 2017
  • Private Grant  awarded by Janssen 2016 - 2017
  • Private Grant  awarded by ABBVIE INC 2016
  • Effectiveness of DiscontinuinG BisphosphonatEs Study (EDGE)  awarded by National Institute of Arthritis & Musculoskeletal & Skin Diseases/NIH/DHHS 2013 - 2016
  • Private Grant  awarded by AMGEN, INC. 2014 - 2015
  • Private Grant  awarded by AMGEN, INC. 2014 - 2015
  • Private Grant  awarded by Pfizer Inc., U.S. Pharmaceuticals Group 2015
  • Burden of Osteoporosis and Low Bone Density in the United States  awarded by National Osteoporosis Foundation 2012 - 2014
  • NIAMS Multidiscipllinary Clinical Research Center  awarded by National Institute of Arthritis & Musculoskeletal & Skin Diseases/NIH/DHHS 2008 - 2014
  • NIAMS Multidiscipllinary Clinical Research Center - Project 4  awarded by National Institute of Arthritis & Musculoskeletal & Skin Diseases/NIH/DHHS 2008 - 2014
  • Private Grant  awarded by AMGEN, INC. 2013 - 2014
  • Private Grant  awarded by REGENERON PHARMACEUTICALS, INC. 2012 - 2014
  • Private Grant  awarded by ARDEA BIOSCIENCES, INC. 2012 - 2013
  • Private Grant  awarded by ARDEA BIOSCIENCES, INC. 2011 - 2013
  • Does Aggressive Treatment in Early RA Reduce Biomarkers of Cardiovascular Risk?  awarded by University of California, Los Angeles 2010 - 2013
  • Private Grant  awarded by AMGEN, INC. 2012 - 2013
  • Deep South Musculoskeletal Certs (DSMC)  awarded by Agency for Healthcare Research and Quality/DHHS 2007 - 2012
  • Private Grant  awarded by AMGEN, INC. 2010 - 2012
  • Education And Training

  • Doctor of Medicine, Oregon Health Sciences University 1999
  • Master of Public Health, Oregon Health Sciences University 1999
  • Full Name

  • Jeffrey Curtis